iCo Therapeutics Announces Year End 2013 Financial Results

... latent HIV reservoirs which remain in individuals despite enormous therapeutic advances in the treatment of HIV/AIDS. Announced that common shares of Subsequent Events to Year End Completed overnight marketed offering of 16,206,483 units for ...

http://ift.tt/RQtuB7